Ann Catherine Childress, MD


Center for Psychiatry and Behavioral Medicine, Inc.


  • Advisory Board: Neurovance; Shionogi
  • Consultant: Arbor Pharmaceuticals; Ironshore Inc.; Neos Therapeutics, Inc.; NextWave Pharmaceuticals; Novartis Pharmaceutical Corporation; Pfizer Inc.; Rhodes; Shire
  • Research Support: Alcobra Pharma; Arbor Pharmaceuticals; Eli Lilly and Company; Forest Research Institute; Ironshore Inc.; Johnson & Johnson Services, Inc.; Lundbeck Inc; Neos Therapeutics, Inc.; Neurovance; NextWave Pharmaceuticals; Novartis Pharmaceutical Corporation; Noven Pharmaceuticals, Inc.; Otsuka America Pharmaceutical, Inc.; Pfizer Inc.; Purdue Pharma L.P.; Rhodes; Shionogi; Shire; Somerset Pharmaceuticals; Sunovion Pharmaceuticals Inc.; Theravance; Tris Pharma, Inc.
  • Speakers Bureau: Novartis Pharmaceutical Corporation; Pfizer Inc.; Shionogi; Shire
  • Travel Support to attend this meeting: Neos Therapeutics, Inc.
Copyright © 2015 - American Academy of Child Adolescent Psychiatry. All Rights Reserved.